Clinical Trial Update: Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 comparative trial evaluated gamma-hydroxybutyrate versus oxazepam for treating alcohol withdrawal syndrome and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol Withdrawal Syndrome

Drugs mentioned

• OXAZEPAM (OXAZEPAM)
• gamma-hydroxybutyrate (gamma-hydroxybutyric acid)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Alcohol Withdrawal Syndrome, Alcohol Dependence | Phase 4 | Status: COMPLETED